# New stem cell approach targets functional cure for diabetes - News-Medical

> **Newsylist Open Intelligence Dossier** · First detected: 2026-07-13 12:29 UTC · Category: Health · Sources: 5 · Current Velocity: 2.8

## Executive Summary
A new immune-engineered stem cell approach is targeting a functional cure for Type 1 diabetes by eliminating the need for immunosuppression.

## Intelligence Brief
Researchers are exploring a new stem cell approach and immune-engineered cell therapy to treat Type 1 diabetes. This method involves hypoimmune-modified islet cell transplantation, designed to help transplanted cells thrive and provide long-term durability without the use of immunosuppressant drugs.


Coverage from News-Medical, Bioengineer.org, and Newswise emphasizes the pursuit of a functional cure and the mechanisms used to protect transplanted cells. The Manila Times reports that Sana Biotechnology has published long-term data and durability results in The New England Journal of Medicine (NEJM).


Attention is now on Sana Biotech, which is heading to the European Association for the Study of Diabetes (EASD) to provide an update on the cell therapy.

## Verified Facts & Key Claims
### What is the primary goal of this new stem cell approach?
The approach targets a functional cure for Type 1 diabetes.

### Which company is providing updates on this therapy?
Sana Biotechnology is providing updates and has published data in The New England Journal of Medicine.

### Does this treatment require immunosuppression?
According to coverage from The Manila Times, the hypoimmune-modified islet cell transplantation functions without immunosuppression.

## Key People, Organizations & Locations
News-Medical, First Human Trial Explores Immune-Engineered Cell Therapy for Type, Diabetes, Sana Biotech, EASD, New Research Seeks, Help Transplanted Cells Thrive, Diabetes Treatment

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| Bioengineer.org | First Human Trial Explores Immune-Engineered Cell Therapy for Type 1 Diabetes | 2026-07-11 18:29 | [Source Link](https://news.google.com/rss/articles/CBMipAFBVV95cUxQTWhuN0N2VE1tQlBMcHN4c3BjblpSVS1GS1U1cXZpLXc3RjdYMXlrZjltMmd0dTJ1SUJxMldCMmZpbFZDRkNmc1IyQVZFLWRnMl84QlRUXzFqamJXWlNNSUFRU0lYU0c3al8yMkN5eWJwSWNDQ01ZcG9rZjdIbFY4THM1bC1WLVpOOGg1QUtZRWVzTVB6SWpScWR1VGlCakh3eEhMOA?oc=5) |
| Longevity.Technology | Sana Biotech heads to EASD with diabetes cell therapy update | 2026-07-11 18:29 | [Source Link](https://news.google.com/rss/articles/CBMimwFBVV95cUxPMEFXTnk5OFpRUWQxbzFWNnhJWGFodlZ1ZEIwWjQ0cXBoQ3RXd214YWo5RWQ3ZEh5Y1gtZHhfekhEWU56Y0VTTzEzVkRnYVk0R3VLUDZ3dFE1bmY1MmhyZ2ZMcmljQi0tQngwbDc1NXBWM0dYUERKTy02bks1SWFwWDc0ejBNclR4VzlBUjMwbXhIWUptMXJ4MXZ6MA?oc=5) |
| Newswise | New Research Seeks to Help Transplanted Cells Thrive in Type 1 Diabetes Treatment | 2026-07-11 18:29 | [Source Link](https://news.google.com/rss/articles/CBMitgFBVV95cUxQZVdqQUpFMWU1Y1B5NzFGMkZIbHNEd2xzb1V0M0RISEFRUEY1MjE3NFJnQTlaM2FhQXM1TWVkc1h5eDFYT3ZuM2s1QWhOQU5UemZLWUNIdEQwQ3ZUV000TUZkR2lMS3dmMFJ1VmdsNjNrR2FOd1VjZ2tFZGdlTl9KVVNXUjQ5aS0ycHdXelVGR2pVellHLWU2VWlLRlRkYk5hQ2luaV9VbGFkM0xsd3ZhVTlBMjN4QdIBtgFBVV95cUxQZVdqQUpFMWU1Y1B5NzFGMkZIbHNEd2xzb1V0M0RISEFRUEY1MjE3NFJnQTlaM2FhQXM1TWVkc1h5eDFYT3ZuM2s1QWhOQU5UemZLWUNIdEQwQ3ZUV000TUZkR2lMS3dmMFJ1VmdsNjNrR2FOd1VjZ2tFZGdlTl9KVVNXUjQ5aS0ycHdXelVGR2pVellHLWU2VWlLRlR) |
| The Manila Times | Sana Biotechnology Announces Follow-On Publication in The New England Journal of Medicine (NEJM) Highlighting Groundbreaking Long-Term Data and Durability of Hypoimmune-Modified Islet Cell Transplantation Without Immunosuppression in Type 1 D | 2026-07-11 18:29 | [Source Link](https://news.google.com/rss/articles/CBMiyANBVV95cUxPNEtibGVNVDBSdmYxYXpLdlg2RGJoOG93Z25XQVhWR1UtRVQ2TXY4Mk5XaWFjdU1sdllERDZWM2xmUkc5eVVGNkZ0cExmVm9BMlVxNWpWQW10emJpOXRDdkZSV2w4SnYzZVdIWTdNQkJORHpSc1oxZHhfTmlGcHlPczBNVzVkQXZxMGlxZXRzQUYtT2FmZlJldnNjbU5fSVdCYlRzSGliUDZMdXN6bkJhUHJHUmxYWUFUUmZqa0FXa0c1RTQ4TnBQbjZORjhUUVFrSm9WVGNVc3NvanhLQzM3RVFNRmgwMkhiX3BuSUJOZXVldkFkV3lpMjBBVGFpYWp5V3Qzd1FtSE0tTGxzd202aUFwMG9kLUpHWVZuaGRoNmNrUGJEY2dnNE4wYTRuOFA1NlNlVDVmdTBXMnpBWE5sTVhzd0YwZGp6V3Y4RWN1bEZHczVRbEl) |
| News-Medical | New stem cell approach targets functional cure for diabetes | 2026-07-11 18:29 | [Source Link](https://news.google.com/rss/articles/CBMiqwFBVV95cUxOVkJBSVcxMWllVC0zUzVXTkxiTVJQa2tSSHQ4TlpuekZvS1ROVmtBWm12dEI5eV9nTXQyUHlmV0JaQTlWaUNlLWpuTDFFMlN0NXlmaFlxUWNCQXJrdno0djVMRjhpWFdIS0tSNC1UMnAyWTBNS0Jmc08xa0U1U1dnTzhVOExnUE9oajhWZEVEMDhaU09INlVWeDB1RjVpUzlxQ1ViVDlET3JuRnM?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-07-13/new-stem-cell-approach-targets-functional-cure-for-diabetes-news-medical*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*